Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Scotland records 6.3% rise in revascularisation ops:

This article was originally published in Clinica

Executive Summary

Scotland has reported a significant rise in the number of revascularisation procedures. NHS Scotland performed 7,200 coronary artery bypass grafts and coronary angioplasties in 2004-05, which is up 6.3% annually, from 6,780. Cardiovascular and cerebrovascular health has improved, according to the latest diagnosis and coronary heart disease (CHD) and stroke (CVD) mortality rates. CHD mortality fell 7.3% across the general population between 2003 and 2004, to 139.4 per 100,000. Among the under-75s, the fall was 9.4%. The rate of new CHD diagnoses fell by 5.1% to 314 per 100,000. CVD mortality fell 6.2% over the same period, to 74.2 per 100,000 and 9.6% (to 22.5 per 100,000) among the under-75s. There was a 5.6% fall in the rate of new CVD diagnoses.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT056870

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel